“Build-To-Buy” Startup Model Alive And Kicking, Invested Execs Say
This article was originally published in The Pink Sheet Daily
Executive Summary
VCs and big pharma execs, speaking at CALBIO, said that even in today’s freer economic climate, investing early in startups, with an option to buy when the time is right, is still a viable business strategy.